These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 29803623)

  • 1. Potential use of IgG endopeptidase in the management of platelet refractoriness due to HLA alloimmunization.
    Burner JD; Goldfinger D
    Transfus Apher Sci; 2018 Jun; 57(3):409-410. PubMed ID: 29803623
    [No Abstract]   [Full Text] [Related]  

  • 2. [Platelet transfusion refractoriness and effective management of platelet alloimmunization].
    Amemiya Y
    Nihon Rinsho; 1997 Sep; 55(9):2392-8. PubMed ID: 9301306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
    Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
    Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal immunoadsorption of anti-HLA antibodies: preliminary clinical experience.
    Palmer A; Taube D; Welsh K; Brynger H; Delin K; Gjörstrup P; Konar J; Söderström T
    Transplant Proc; 1987 Oct; 19(5):3750-1. PubMed ID: 3313909
    [No Abstract]   [Full Text] [Related]  

  • 5. The mechanism of platelet aggregation induced by HLA-related antibodies.
    Brandt JT; Julius CJ; Osborne JM; Anderson CL
    Thromb Haemost; 1996 Nov; 76(5):774-9. PubMed ID: 8950789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 14th International HLA and Immunogenetics Workshop: report on understanding antibodies in transplantation.
    Zachary AA; Montgomery RA; Jordan SC; Reinsmoen NL; Claas FH; Reed EF
    Tissue Antigens; 2007 Apr; 69 Suppl 1():160-73. PubMed ID: 17445194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients.
    Fontaine MJ; Kuo J; Chen G; Galel SA; Miller E; Sequeira F; Viele M; Goodnough LT; Tyan DB
    Transfusion; 2011 Dec; 51(12):2611-8. PubMed ID: 21615749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
    Toor AA; Choo SY; Little JA
    Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1q-binding anti-HLA antibodies do not predict platelet transfusion failure in Trial to Reduce Alloimmunization to Platelets study participants.
    Jackman RP; Lee JH; Pei R; Bolgiano D; Lebedeva M; Slichter SJ; Norris PJ
    Transfusion; 2016 Jun; 56(6):1442-50. PubMed ID: 27079754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Earlier detection of HLA alloimmunization in platelet transfusion refractoriness by flow cytometric analysis.
    Sato S; Sakurai T; Yamamoto Y; Maekawa I; Ikeda H
    Transfusion; 2005 Aug; 45(8):1399-401. PubMed ID: 16078932
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
    Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
    Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing human alloimmunization as a strategy for inducing HIV type 1 neutralizing anti-HLA responses.
    Leith JG; Clark DA; Matthews TJ; Rosenthal KL; Luscher MA; Barber BH; MacDonald KS
    AIDS Res Hum Retroviruses; 2003 Nov; 19(11):957-65. PubMed ID: 14678602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness].
    Basire A; Picard C
    Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of HLA antibodies in transfused patients with and without red cell antibodies.
    Buetens O; Shirey RS; Goble-Lee M; Houp J; Zachary A; King KE; Ness PM
    Transfusion; 2006 May; 46(5):754-6. PubMed ID: 16686842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-thymocyte globulin induced thrombocytopenia.
    Lazarchick J; Russell R; Horn B
    Ann Clin Lab Sci; 1990; 20(6):373-8. PubMed ID: 2073086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin G subclass analysis of HLA donor specific antibodies in heart and renal transplant recipients.
    Cicciarelli JC; Kasahara N; Lemp NA; Adamson R; Dembitsky W; Browne B; Steinberg S
    Clin Transpl; 2013; ():413-22. PubMed ID: 25095537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma radiation does not prevent transfusion-induced HLA alloimmunization.
    Ohto H
    Transfusion; 1997 Aug; 37(8):878-9. PubMed ID: 9280338
    [No Abstract]   [Full Text] [Related]  

  • 18. [Transfusion of platelet concentrates].
    Rieux C; Lee K; Lavaud A; Bierling P
    Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Biology of IgG Subclasses and Their Clinical Relevance to Transplantation.
    Valenzuela NM; Schaub S
    Transplantation; 2018 Jan; 102(1S Suppl 1):S7-S13. PubMed ID: 29266057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia.
    Laundy GJ; Bradley BA; Rees BM; Younie M; Hows JM
    Transfusion; 2004 Jun; 44(6):814-25. PubMed ID: 15157245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.